Haemonetics | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Avanos Medical USD 98M 5.1M 2024-12
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Boston Scientific USD 3.1B 194M 2024-12
Cooper Companies USD 660.2M 17.5M 2025-01
Fresenius EUR 1.42B 52M 2024-12
Fresenius Medical Care EUR 1.27B 124.43M 2024-12
Globus Medical USD 393.86M 38.67M 2024-12
Haemonetics USD 196.57M 5.37M 2024-12
Hologic USD 580.5M 22.8M 2024-12
ICU Medical USD 227.26M 22.41M 2024-12
Intuitive Surgical USD 1.64B 268.3M 2024-12
Masimo USD 244.7M 18.5M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.98M 15.45M 2024-12
Neogen USD 113.33M 8.4M 2024-11
Quidel USD 326.1M 26.2M 2024-12
ResMed USD 751.28M 34.06M 2024-12
STAAR Surgical USD 31.65M 36.84M 2024-12
Steris USD 610.33M 31.54M 2024-12
Stryker USD 4.2B 681M 2024-12
Teleflex USD 439.92M 9.74M 2024-12
Terumo JPY 145.12B 5.66B 2024-12
Thermo Fisher Scientific USD 4.82B 494M 2024-12
US Physical Therapy USD 32.77M 210K 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Haemonetics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.